Tag: edoxaban

Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical...

According to Geu-Ru Hong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea), edoxaban may be an alternative to warfarin...
The results of the safety profile and efficacy of Lixiana study

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...

Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in...

The ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients...

Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban

The first patient has been enrolled into Daiichi Sankyo’s ENTRUST-AF PCI study. The multinational, randomised phase 3b study will evaluate a treatment regimen based...